CD4 T cells in hepatic immune tolerance

Journal of Autoimmunity

Volumn 34, Issue 1, 2010, Pages 23-28

  Carambia, Antonella ^a   Herkel, Johannes ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Immune deviation; Immune tolerance; Liver cell types; Regulatory T cells

Indexed keywords

CYTOKINE; INTERLEUKIN 10; PROGRAMMED DEATH 1 RECEPTOR; TRANSFORMING GROWTH FACTOR BETA;

ALLOGRAFT; ANTIGEN PRESENTING CELL; AUTOIMMUNE DISEASE; CD4+ T LYMPHOCYTE; CELL STIMULATION; CHRONIC HEPATITIS; HUMAN; IMMUNOLOGICAL TOLERANCE; INFLAMMATORY DISEASE; KUPFFER CELL; LIVER; LIVER SINUSOID; LIVER TRANSPLANTATION; MICROENVIRONMENT; NONHUMAN; PORTAL VEIN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; STELLATE CELL; VIRUS HEPATITIS;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, CD; APOPTOSIS REGULATORY PROTEINS; CD4-POSITIVE T-LYMPHOCYTES; HUMANS; IMMUNE TOLERANCE; IMMUNOTHERAPY; INTERLEUKIN-10; LIVER; LYMPHOCYTE ACTIVATION; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA;

EID: 75149129437     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2009.08.006     Document Type: Review

References (78)

1. Racanelli V., and Rehermann B. The liver as an immunological organ. Hepatology 43 (2006) S54-S62
2. Calne R.Y., Sells R.A., Pena J.R., Davis D.R., Millard P.R., Herbertson B.M., et al. Induction of immunological tolerance by porcine liver allografts. Nature 223 (1969) 472-476
3. Cantor H.M., and Dumont A.E. Hepatic suppression of sensitization to antigen absorbed into the portal system. Nature 215 (1967) 744-745
4. Rehermann B., and Nascimbeni M. Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol 5 (2005) 215-229
5. Klugewitz K., Blumenthal-Barby F., Schrage A., Knolle P.A., Hamann A., and Crispe I.N. Immunomodulatory effects of the liver: deletion of activated CD4+ effector cells and suppression of IFN-gamma-producing cells after intravenous protein immunization. J Immunol 169 (2002) 2407-2413
6. Goubier A., Dubois B., Gheit H., Joubert G., Villard-Truc F., Asselin-Paturel C., et al. Plasmacytoid dendritic cells mediate oral tolerance. Immunity 29 (2008) 464-475
7. Holz L.E., Benseler V., Bowen D.G., Bouillet P., Strasser A., O'Reilly L., et al. Intrahepatic murine CD8 T-cell activation associates with a distinct phenotype leading to Bim-dependent death. Gastroenterology 135 (2008) 989-997
8. Lüth S., Huber S., Schramm C., Buch T., Zander S., Stadelmann C., et al. Ectopic expression of neural autoantigen in mouse liver suppresses experimental autoimmune neuroinflammation by inducing antigen-specific Tregs. J Clin Invest 118 (2008) 3403-3410
9. Knolle P.A., Schmitt E., Jin S., Germann T., Duchmann R., Hegenbarth S., et al. Induction of cytokine production in naive CD4(+) T cells by antigen-presenting murine liver sinusoidal endothelial cells but failure to induce differentiation toward Th1 cells. Gastroenterology 116 (1999) 1428-1440
10. Wiegard C., Wolint P., Frenzel C., Cheruti U., Schmitt E., Oxenius A., et al. Defective T helper response of hepatocyte-stimulated CD4 T cells impairs antiviral CD8 response and viral clearance. Gastroenterology 133 (2007) 2010-2018
11. Bowen D.G., Zen M., Holz L., Davis T., McCaughan G.W., and Bertolino P. The site of primary T cell activation is a determinant of the balance between intrahepatic tolerance and immunity. J Clin Invest 114 (2004) 701-712
12. Warren A., Le Couteur D.G., Fraser R., Bowen D.G., McCaughan G.W., and Bertolino P. T lymphocytes interact with hepatocytes through fenestrations in murine liver sinusoidal endothelial cells. Hepatology 44 (2006) 1182-1190
13. Limmer A., Ohl J., Kurts C., Ljunggren H.G., Reiss Y., Groettrup M., et al. Efficient presentation of exogenous antigen by liver endothelial cells to CD8+ T cells results in antigen-specific T-cell tolerance. Nat Med 6 (2000) 1348-1354
14. Schildberg F.A., Hegenbarth S.I., Schumak B., Scholz K., Limmer A., and Knolle P.A. Liver sinusoidal endothelial cells veto CD8 T cell activation by antigen-presenting dendritic cells. Eur J Immunol 38 (2008) 957-967
15. You Q., Cheng L., Kedl R.M., and Ju C. Mechanism of T cell tolerance induction by murine hepatic Kupffer cells. Hepatology 48 (2008) 978-990
16. Roland C.R., Walp L., Stack R.M., and Flye M.W. Outcome of Kupffer cell antigen presentation to a cloned murine Th1 lymphocyte depends on the inducibility of nitric oxide synthase by IFN-gamma. J Immunol 153 (1994) 5453-5464
17. Knolle P., Schlaak J., Uhrig A., Kempf P., Meyer zum Büschenfelde K.H., and Gerken G. Human Kupffer cells secrete IL-10 in response to lipopolysaccharide (LPS) challenge. J Hepatol 22 (1995) 226-229
18. Probst H.C., McCoy K., Okazaki T., Honjo T., and van den Broek M. Resting dendritic cells induce peripheral CD8+ T cell tolerance through PD-1 and CTLA-4. Nat Immunol 6 (2005) 280-286
19. Lian Z.X., Okada T., He X.S., Kita H., Liu Y.J., Ansari A.A., et al. Heterogeneity of dendritic cells in the mouse liver: identification and characterization of four distinct populations. J Immunol 170 (2003) 2323-2330
20. Pillarisetty V.G., Shah A.B., Miller G., Bleier J.I., and DeMatteo R.P. Liver dendritic cells are less immunogenic than spleen dendritic cells because of differences in subtype composition. J Immunol 172 (2004) 1009-1017
21. Viñas O., Bataller R., Sancho-Bru P., Ginès P., Berenguer C., Enrich C., et al. Human hepatic stellate cells show features of antigen-presenting cells and stimulate lymphocyte proliferation. Hepatology 38 (2003) 919-929
22. Winau F., Hegasy G., Weiskirchen R., Weber S., Cassan C., Sieling P.A., et al. Ito cells are liver-resident antigen-presenting cells for activating T cell responses. Immunity 26 (2007) 117-129
23. Jiang G., Yang H.R., Wang L., Wildey G.M., Fung J., Qian S., et al. Hepatic stellate cells preferentially expand allogeneic CD4+ CD25+ FoxP3+ regulatory T cells in an IL-2-dependent manner. Transplantation 86 (2008) 1492-1502
24. Chen C.H., Kuo L.M., Chang Y., Wu W., Goldbach C., Ross M.A., et al. In vivo immune modulatory activity of hepatic stellate cells in mice. Hepatology 44 (2006) 1171-1181
25. Herkel J., Jagemann B., Wiegard C., Lazaro J.F., Lueth S., Kanzler S., et al. MHC class II-expressing hepatocytes function as antigen-presenting cells and activate specific CD4 T lymphocyutes. Hepatology 37 (2003) 1079-1085
26. Bettelli E., Oukka M., and Kuchroo V.K. T(H)-17 cells in the circle of immunity and autoimmunity. Nat Immunol 8 (2007) 345-350
27. Sakaguchi S., Yamaguchi T., Nomura T., and Ono M. Regulatory T cells and immune tolerance. Cell 133 (2008) 775-787
28. Nishimura T., and Ohta A. A critical role for antigen-specific Th1 cells in acute liver injury in mice. J Immunol 162 (1999) 6503-6509
29. Jones D.E., Palmer J.M., Burt A.D., Walker C., Robe A.J., and Kirby J.A. Bacterial motif DNA as an adjuvant for the breakdown of immune self-tolerance to pyruvate dehydrogenase complex. Hepatology 36 (2002) 679-686
30. Bertolino P. Interleukin-22, interleukin-17, and other cytokines: a wall is coming down. Hepatology 47 (2008) 345-348
31. Lan R.Y., Salunga T.L., Tsuneyama K., Lian Z.X., Yang G.X., Hsu W., et al. Hepatic IL-17 responses in human and murine primary biliary cirrhosis. J Autoimmun 3 (2009) 43-51
32. Lemmers A., Moreno C., Gustot T., Maréchal R., Degré D., Demetter P., et al. The interleukin-17 pathway is involved in human alcoholic liver disease. Hepatology 49 (2009) 646-657
33. Hamada S., Umemura M., Shiono T., Tanaka K., Yahagi A., Begum M.D., et al. IL-17A produced by gamma/delta T cells plays a critical role in innate immunity against listeria monocytogenes infection in the liver. J Immunol 181 (2008) 3456-3463
34. Watanabe T., Katsukura H., Shirai Y., Yamori M., Nishi T., Chiba T., et al. A liver tolerates a portal antigen by generating CD11c+ cells, which select Fas ligand+ Th2 cells via apoptosis. Hepatology 3 (2003) 403-412
35. Cabillic F., Rougier N., Basset C., Lecouillard I., Quelvennec E., Toujas L., et al. Hepatic environment elicits monocyte differentiation into a dendritic cell subset directing Th2 response. J Hepatol 44 (2006) 552-559
36. Moseman E.A., Liang X., Dawson A.J., Panoskaltsis-Mortari A., Krieg A.M., Liu Y.J., et al. Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4+CD25+ regulatory T cells. J Immunol 173 (2004) 4433-4442
37. Bamboat Z.M., Stableford J.A., Plitas G., Burt B.M., Nguyen H.M., Welles A.P., et al. Human liver dendritic cells promote T cell hyporesponsiveness. J Immunol 182 (2009) 1901-1911
38. Tsai S.L., Liaw Y.F., Chen M.H., Huang C.Y., and Kuo G.C. Detection of type 2-like T-helper cells in hepatitis C virus infection: implications for hepatitis C virus chronicity. Hepatology 25 (1997) 449-458
39. Semmo N., Day C.L., Ward S.M., Lucas M., Harcourt G., Loughry A., et al. Preferential loss of IL-2-secreting CD4+ T helper cells in chronic HCV infection. Hepatology 41 (2005) 1019-1028
40. Fife B.T., and Bluestone J.A. Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways. Immunol Rev 224 (2008) 166-182
41. Keir M.E., Butte M.J., Freeman G.J., and Sharpe A.H. PD-1 and its ligands in tolerance and immunity. Annu Rev Immunol 26 (2008) 677-704
42. Iwai Y., Terawaki S., Ikegawa M., Okazaki T., and Honjo T. PD-1 inhibits antiviral immunity at the effector phase in the liver. J Exp Med 198 (2003) 39-50
43. Urbani S., Amadei B., Tola D., Pedrazzi G., Sacchelli L., Cavallo M.C., et al. Restoration of HCV-specific T cell functions by PD-1/PD-L1 blockade in HCV infection: effect of viremia levels and antiviral treatment. J Hepatol 48 (2008) 548-558
44. Nakamoto N., Kaplan D.E., Coleclough J., Li Y., Valiga M.E., Kaminski M., et al. Functional restoration of HCV-specific CD8 T cells by PD-1 blockade is defined by PD-1 expression and compartmentalization. Gastroenterology 134 (2008) 1927-1937
45. Dong H., Zhu G., Tamada K., Flies D.B., van Deursen J.M., and Chen L. B7-H1 determines accumulation and deletion of intrahepatic CD8(+) T lymphocytes. Immunity 20 (2004) 327-336
46. Barber D.L., Wherry E.J., Masopust D., Zhu B., Allison J.P., Sharpe A.H., et al. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439 (2006) 682-687
47. Ciurea A., Hunziker L., Klenerman P., Hengartner H., and Zinkernagel R.M. Impairment of CD4(+) T cell responses during chronic virus infection prevents neutralizing antibody responses against virus escape mutants. J Exp Med 193 (2001) 297-305
48. Nakamoto N., Cho H., Shaked A., Olthoff K., Valiga M.E., Kaminski M., et al. Synergistic reversal of intrahepatic HCV-specific CD8 T cell exhaustion by combined PD-1/CTLA-4 blockade. PLoS Pathog 5 (2009) e1000313
49. Jonuleit H., and Schmitt E. The regulatory T cell family: distinct subsets and their interrelations. J Immunol 171 (2003) 6323-6327
50. Bopp T., Becker C., Klein M., Klein-Hessling S., Palmetshofer A., Serfling E., et al. Cyclic adenosine monophosphate is a key component of regulatory T cell-mediated suppression. J Exp Med 204 (2007) 1303-1310
51. Ostroukhova M., Qi Z., Oriss T.B., Dixon-McCarthy B., Ray P., and Ray A. Treg-mediated immunosuppression involves activation of the Notch-HES1 axis by membrane-bound TGF-beta. J Clin Invest 116 (2006) 996-1004
52. Sansom D.M., and Walker L.S. The role of CD28 and cytotoxic T-lymphocyte antigen-4 (CTLA-4) in regulatory T-cell biology. Immunol Rev 212 (2006) 131-148
53. Esparza E.M., and Arch R.H. Signaling triggered by glucocorticoid-induced tumor necrosis factor receptor family-related gene: regulation at the interface between regulatory T cells and immune effector cells. Front Biosci 11 (2006) 1448-1465
54. Walker L.S., Chodos A., Eggena M., Dooms H., and Abbas A.K. Antigen-dependent proliferation of CD4+ CD25+ regulatory T cells in vivo. J Exp Med 198 (2003) 249-258
55. Liang S., Alard P., Zhao Y., Parnell S., Clark S.L., and Kosiewicz M.M. Conversion of CD4+ CD25- cells into CD4+ CD25+ regulatory T cells in vivo requires B7 costimulation, but not the thymus. J Exp Med 201 (2005) 127-137
56. Chen W., Jin W., Hardegen N., Lei K.J., Li L., Marinos N., et al. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 198 (2003) 1875-1886
57. Huber S., Schramm C., Lehr H.A., Mann A., Schmitt S., Becker C., et al. Cutting edge: TGF-beta signaling is required for the in vivo expansion and immunosuppressive capacity of regulatory CD4+CD25+ T cells. J Immunol 173 (2004) 6526-6531
58. Longhi M.S., Ma Y., Bogdanos D.P., Cheeseman P., Mieli-Vergani G., and Vergani D. Impairment of CD4(+)CD25(+) regulatory T-cells in autoimmune liver disease. J Hepatol 41 (2004) 31-37
59. Lan R.Y., Cheng C., Lian Z.X., Tsuneyama K., Yang G.X., Moritoki Y., et al. Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis. Hepatology 43 (2006) 729-737
60. Longhi M.S., Hussain M.J., Mitry R.R., Arora S.K., Mieli-Vergani G., Vergani D., et al. Functional study of CD4+CD25+ regulatory T cells in health and autoimmune hepatitis. J Immunol 176 (2006) 4484-4491
61. Erhardt A., Biburger M., Papadopoulos T., and Tiegs G. IL-10, regulatory T cells, and Kupffer cells mediate tolerance in concanavalin A-induced liver injury in mice. Hepatology 45 (2007) 475-485
62. Wei H.X., Chuang Y.H., Li B., Wei H., Sun R., Moritoki Y., et al. CD4+ CD25+ Foxp3+ regulatory T cells protect against T cell-mediated fulminant hepatitis in a TGF-beta-dependent manner in mice. J Immunol 181 (2008) 7221-7229
63. Ma X., Hua J., Mohamood A.R., Hamad A.R., Ravi R., and Li Z. A high-fat diet and regulatory T cells influence susceptibility to endotoxin-induced liver injury. Hepatology 46 (2007) 1519-1529
64. Rushbrook S.M., Ward S.M., Unitt E., Vowler S.L., Lucas M., and Klenerman P. Alexander GJ Regulatory T cells suppress in vitro proliferation of virus-specific CD8+ T cells during persistent hepatitis C virus infection. J Virol 79 (2005) 7852-7859
65. Boettler T., Spangenberg H.C., Neumann-Haefelin C., Panther E., Urbani S., Ferrari C., et al. T cells with a CD4+CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection. J Virol 79 (2005) 7860-7867
66. Ward S.M., Fox B.C., Brown P.J., Worthington J., Fox S.B., Chapman R.W., et al. Quantification and localisation of FOXP3+ T lymphocytes and relation to hepatic inflammation during chronic HCV infection. J Hepatol 47 (2007) 316-324
67. Accapezzato D., Francavilla V., Paroli M., Casciaro M., Chircu L.V., Cividini A., et al. Hepatic expansion of a virus-specific regulatory CD8(+) T cell population in chronic hepatitis C virus infection. J Clin Invest 113 (2004) 963-972
68. Abel M., Sène D., Pol S., Bourlière M., Poynard T., Charlotte F., et al. Intrahepatic virus-specific IL-10-producing CD8 T cells prevent liver damage during chronic hepatitis C virus infection. Hepatology 44 (2006) 1607-1616
69. Wiegard C., Frenzel C., Herkel J., Kallen K.J., Schmitt E., and Lohse A.W. Murine liver antigen presenting cells control suppressor activity of CD4+CD25+ regulatory T cells. Hepatology 42 (2005) 193-199
70. Franceschini D., Paroli M., Francavilla V., Videtta M., Morrone S., Labbadia G., et al. PD-L1 negatively regulates CD4+CD25+Foxp3+ Tregs by limiting STAT-5 phosphorylation in patients chronically infected with HCV. J Clin Invest 119 (2009) 551-564
71. Safadi R., Alvarez C.E., Ohta M., Brimnes J., Kraus T., Mehal W., et al. Enhanced oral tolerance in transgenic mice with hepatocyte secretion of IL-10. J Immunol 175 (2005) 3577-3583
72. Ye F., Yan S., Xu L., Jiang Z., Liu N., Xiong S., et al. Tr1 regulatory T cells induced by ConA pretreatment prevent mice from ConA-induced hepatitis. Immunol Lett 122 (2009) 198-207
73. Nelson D.R., Lauwers G.Y., Lau J.Y., and Davis G.L. Interleukin 10 treatment reduces fibrosis in patients with chronic hepatitis C: a pilot trial of interferon nonresponders. Gastroenterology 118 (2000) 655-660
74. Brooks D.G., Trifilo M.J., Edelmann K.H., Teyton L., McGavern D.B., and Oldstone M.B. Interleukin-10 determines viral clearance or persistence in vivo. Nat Med 12 (2006) 1301-1309
75. Longenecker G., Thyagarajan T., Nagineni C.N., Flanders K.C., Factor V., Miller G., et al. Endocrine expression of the active form of TGF-beta1 in the TGF-beta1 null mice fails to ameliorate lethal phenotype. Cytokine 18 (2002) 43-50
76. Herbert D.R., Orekov T., Perkins C., and Finkelman F.D. IL-10 and TGF-beta redundantly protect against severe liver injury and mortality during acute schistosomiasis. J Immunol 181 (2008) 7214-7220
77. Alatrakchi N., Graham C.S., van der Vliet H.J., Sherman K.E., Exley M.A., and Koziel M.J. Hepatitis C virus (HCV)-specific CD8+ cells produce transforming growth factor beta that can suppress HCV-specific T-cell responses. J Virol 81 (2007) 5882-5892
78. Lang K.S., Georgiev P., Recher M., Navarini A.A., Bergthaler A., Heikenwalder M., et al. Immunoprivileged status of the liver is controlled by Toll-like receptor 3 signaling. J Clin Invest 116 (2006) 2456-2463